Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 30.61 USD 0.43% Market Closed
Market Cap: 437.4m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SRDX stock under the Base Case scenario is 25.28 USD. Compared to the current market price of 30.61 USD, Surmodics Inc is Overvalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SRDX Relative Value
Base Case
25.28 USD
Overvaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
79
vs Industry
34
Median 3Y
4.2
Median 5Y
4.9
Industry
2.2
Forward
3.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
10
Median 3Y
-22.2
Median 5Y
29.5
Industry
22.5
Forward
-81.1
More Details
381.8
P/OCF
P/OCF
Price to OCF
381.8
vs History
9
vs Industry
0
Median 3Y
18.5
Median 5Y
37.1
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
19
Median 3Y
-38.9
Median 5Y
19.7
Industry
19.7
More Details
3.9
P/B
P/B
Price to Book Value
3.9
vs History
71
vs Industry
21
Median 3Y
4.1
Median 5Y
4.3
Industry
2.1
More Details
3.5
EV/S
EV/S
Enterprise Value to Sales
3.5
vs History
77
vs Industry
32
Median 3Y
4.1
Median 5Y
4.7
Industry
2.3
Forward
3.3
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
74
vs Industry
46
Median 3Y
5.2
Median 5Y
5.9
Industry
4.9
More Details
148.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
148.6
vs History
14
vs Industry
2
Median 3Y
21.9
Median 5Y
39.2
Industry
11.9
Forward
29.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
13
Median 3Y
-18.7
Median 5Y
20
Industry
16.4
Forward
-90.7
More Details
381.3
EV/OCF
EV/OCF
Enterprise Value to OCF
381.3
vs History
9
vs Industry
0
Median 3Y
18
Median 5Y
34
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
18
Median 3Y
-19.7
Median 5Y
33.3
Industry
17.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
73
vs Industry
25
Median 3Y
3.4
Median 5Y
3.9
Industry
1.8
More Details

Multiples Across Competitors

SRDX Competitors Multiples
Surmodics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Surmodics Inc
NASDAQ:SRDX
437.5m USD 3.5 -30.4 148.6 -79.4
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
65.8B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
57.1B EUR 2.5 28.8 16.4 23.4
US
Edwards Lifesciences Corp
NYSE:EW
41.8B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.4 12.9 15.7

See Also

Summary
SRDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRDX stock valuation using valuation multiples.
Wall Street Estimates
SRDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.